Free Trial

Financial Counselors Inc. Reduces Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

DENTSPLY SIRONA logo with Medical background
Remove Ads

Financial Counselors Inc. lessened its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 85.6% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 34,713 shares of the medical instruments supplier's stock after selling 205,999 shares during the quarter. Financial Counselors Inc.'s holdings in DENTSPLY SIRONA were worth $659,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Prudential Financial Inc. increased its position in shares of DENTSPLY SIRONA by 62.1% during the fourth quarter. Prudential Financial Inc. now owns 334,114 shares of the medical instruments supplier's stock valued at $6,108,000 after acquiring an additional 128,056 shares in the last quarter. Vanguard Group Inc. lifted its holdings in shares of DENTSPLY SIRONA by 0.3% during the fourth quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier's stock valued at $383,078,000 after purchasing an additional 65,478 shares in the last quarter. LPL Financial LLC raised its position in DENTSPLY SIRONA by 52.2% in the 4th quarter. LPL Financial LLC now owns 115,108 shares of the medical instruments supplier's stock worth $2,185,000 after buying an additional 39,498 shares during the last quarter. KLP Kapitalforvaltning AS bought a new position in DENTSPLY SIRONA during the 4th quarter valued at about $780,000. Finally, American Century Companies Inc. boosted its holdings in shares of DENTSPLY SIRONA by 38.2% during the 4th quarter. American Century Companies Inc. now owns 3,873,645 shares of the medical instruments supplier's stock valued at $73,522,000 after acquiring an additional 1,071,604 shares during the last quarter. Institutional investors own 95.70% of the company's stock.

Remove Ads

Insider Activity

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 15,142 shares of DENTSPLY SIRONA stock in a transaction dated Monday, March 3rd. The stock was acquired at an average cost of $16.51 per share, with a total value of $249,994.42. Following the purchase, the director now directly owns 81,971 shares in the company, valued at $1,353,341.21. This represents a 22.66 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 0.52% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the company. Wells Fargo & Company lowered their target price on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a report on Friday, February 28th. UBS Group decreased their price target on DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating on the stock in a report on Tuesday, December 3rd. Robert W. Baird reduced their price objective on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research note on Friday, February 28th. StockNews.com downgraded shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Finally, Needham & Company LLC restated a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Twelve investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat, DENTSPLY SIRONA currently has a consensus rating of "Hold" and a consensus target price of $23.33.

Get Our Latest Stock Analysis on XRAY

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock traded up $0.08 during mid-day trading on Wednesday, reaching $14.73. The stock had a trading volume of 398,028 shares, compared to its average volume of 2,769,799. DENTSPLY SIRONA Inc. has a 1-year low of $14.50 and a 1-year high of $33.02. The firm has a market cap of $2.93 billion, a price-to-earnings ratio of -7.11, a PEG ratio of 1.80 and a beta of 0.98. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The business's fifty day moving average is $17.55 and its 200-day moving average is $20.05.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be paid a dividend of $0.16 per share. The ex-dividend date is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.34%. DENTSPLY SIRONA's payout ratio is currently -14.07%.

DENTSPLY SIRONA Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Stories

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Should You Invest $1,000 in DENTSPLY SIRONA Right Now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Quantum Stocks Are Heating Up Again — 7 to Watch Now

Quantum Stocks Are Heating Up Again — 7 to Watch Now

After a brief dip earlier this year, fresh momentum has reignited interest; from penny plays to tech giants, these quantum stocks could lead the next surge.

Related Videos

Is There Still Money in AI? How to Invest in the Next Big Wave
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
Elon Musk’s First 100 Days of DOGE: 3 AI Stocks Ready to Soar

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads